MedTrace Logo

Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation

NCT06756906 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-01-03

No results posted yet for this study

Summary

Burn-related pain is severe and often difficult to manage. Burn patients often require high doses of opioids and anxiolytics. Anesthetic agents used during sedation such as benzodiazepines, propofol and opioids can cause respiratory depression, predisposing patients to hypoventilation and hypoxemia due to airway obstruction. Oxygen is administered to patients with a standard nasal cannula during sedation. High Flow Nasal Oxygen (HFNO) helps to improve the oxygenation of patients with respiratory distress by delivering high flow humidified oxygen through the nasal cannula at a high rate of up to 40-70 liters per minute. The aim of this study was to compare the effects of HFNO and nasal oxygen therapy in preventing hypoxemia in deeply sedated burn patients.

Conditions

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Ezgi Erkılıç, Assoc Prof · Ankara Bilkent City Hospital, Department of Anesthesiology

  • Huriye Bilge Tuncer, MD · Ankara Bilkent City Hospital, Department of Anesthesiology

  • Merve Akın, Assoc Prof · Ankara Bilkent City Hospital, Department of General Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2025-01-27
Completion
2025-02-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06756906 on ClinicalTrials.gov